OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
14
Results
Show all
Save search
Copy query
Show results for
Unknown
(14)
Publication Date
Release Date
2023
(2)
2022
(2)
2016
(2)
2024
(1)
2021
(1)
2020
(1)
2019
(1)
2018
(1)
2017
(1)
2011
(1)
2010
(1)
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
The Toll-Like Receptor 4 Antagonist Eritoran Protects Mice from Lethal Filovirus Challenge.
Not available
S-EPMC5405229
|
biostudies-literature
Cite
Combinations of the azaquinazoline anti-
Wolbachia
agent, AWZ1066S, with benzimidazole anthelmintics synergise to mediate sub-seven-day sterilising and curative efficacies in experimental models of filariasis.
Not available
S-EPMC10867176
|
biostudies-literature
Cite
Allosteric inhibitors of Mycobacterium tuberculosis tryptophan synthase.
Not available
S-EPMC7020977
|
biostudies-literature
Cite
Vaccine-Linked Chemotherapy Improves Benznidazole Efficacy for Acute Chagas Disease.
Not available
S-EPMC5865041
|
biostudies-literature
Cite
Therapeutical targeting of nucleic acid-sensing Toll-like receptors prevents experimental cerebral malaria.
Not available
S-EPMC3048158
|
biostudies-literature
Cite
Vaccine-linked chemotherapy improves cardiac structure and function in a mouse model of chronic Chagas disease.
Not available
S-EPMC9947347
|
biostudies-literature
Cite
Vaccine-linked chemotherapy induces IL-17 production and reduces cardiac pathology during acute Trypanosoma cruzi infection.
Not available
S-EPMC7865072
|
biostudies-literature
Cite
A novel antagonist of the prostaglandin E(2) EP(4) receptor inhibits Th1 differentiation and Th17 expansion and is orally active in arthritis models.
Not available
S-EPMC2874852
|
biostudies-literature
Cite
Vaccine-linked chemotherapy with a low dose of benznidazole plus a bivalent recombinant protein vaccine prevents the development of cardiac fibrosis caused by Trypanosoma cruzi in chronically-infected BALB/c mice.
Not available
S-EPMC9499242
|
biostudies-literature
Cite
Novel strategies for targeting innate immune responses to influenza.
Not available
S-EPMC5125448
|
biostudies-literature
Cite
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets